SK biopharmaceuticals

About:

Specialty Pharmaceutical Company

Twitter/X: skbiophama

Top Investors: Goldman Sachs, KB Investment, HBM Healthcare Investments, Korea Drug Development Fund, WTT Investment

Description:

SK biopharmaceuticals aims to become a top tier specialty pharmaceutical company with global new drugs & innovative pipeline in CNS / metabolic disorders and to provide world class specialized pharmaceutical manufacturing services.

Total Funding Amount:

$180M

Headquarters Location:

Seongnam, Kyonggi-do, South Korea

Founded Date:

2011-01-01

Founders:

Number of Employees:

251-500

Last Funding Date:

2022-11-14

IPO Status:

Private

Industries: